Intuitive Surgical's da Vinci 5 platform launch is driving an installed base refresh cycle and accelerating procedure adoption, particularly in general surgery and bariatrics. International growth (Japan, Korea, Germany) compounds US share gains. Recurring instruments and services revenue grows with procedure volumes. Premium valuation reflects durable competitive moat but limits margin of safety.
Signals scoped to US · Company-specific tagging coming soon.